Skip to main contentSkip to navigation
Sirius Investors
Royalty Pharma plc

Royalty Pharma plc

RPRX
NASDAQHealthcare

Revenue Analysis - RPRX

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

RPRX Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Financial Royalty Assets

0.0% of total revenue

$595.0M

Royalty Income, Other

0.0% of total revenue

$35.6M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Financial Royalty Assets
Royalty Income, Other
3/31/2026$595.0M$35.6M
12/31/2025$592.4M$29.6M
9/30/2025$578.8M$30.5M
6/30/2025$550.4M$28.2M
3/31/2025$539.5M$28.8M
12/31/2024$1.1B$56.2M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Royalty Income, Other+20.4%

Earnings Reports

Want to see how RPRX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports